| Date | Title | Description | Source |
| 05.05.2018 | A life sciences firm run by a top VC and a cofounder of Alph... | There’s no end to the number of fascinating devices and therapies being created right now in the fie... | techcrunch... |
| 16.11.2017 | Heartland startup funding in 2017 shows a North-South divide | While Silicon Valley is known as the heart of tech and home to the world’s top tier venture capital ... | venturebea... |
| 16.11.2017 | Heartland startup funding in 2017 shows a North-South divide | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI an... | venturebea... |
| 15.09.2017 | Intarcia and Numab Reach Key Milestone |
This milestone, achieved by utilizing Numab’s innovative discovery and optimization platform to id... | startuptic... |
| 04.05.2017 | NEA’s Ed Mathers talks biopharma investment trends and why i... | In a recent phone interview, Mathers discussed his investment principles ahead of a panel appearance... | medcitynew... |
| 01.01.2017 | Intarcia Secures Second Close of the Series EE Equity Financ... | Intarcia Therapeutics, Inc., today announced it has completed its second major close of the Series E... | citybizlis... |
| 30.12.2016 | Intarcia Therapeutics Raises $206M in Second Close of Series... | Intarcia Therapeutics, Inc., a Boston, MA-based biopharmaceutical company, secured an additional $20... | finsmes.co... |
| 15.09.2016 | Intarcia Therapeutics Holds $215M First Close of Equity Fina... | Intarcia Therapeutics, Inc., a Boston, MA-based biopharmaceutical company, held $215m first close of... | finsmes.co... |
| 17.06.2016 | Philanthropist Bill Gates talks public health, biotech, and ... | Bill Gates became one of the richest men in history after cofounding Microsoft. His impact on the wo... | statnews.c... |
| 18.08.2015 | Intarcia’s type 2 diabetes implant more effective than top-s... | This is a big deal in terms of potential improvements to medication adherence: Patients can’t forget... | medcitynew... |
| 01.05.2015 | Intarcia raises $225m to fund diabetes trial | Medtech fundi... | Intarcia adds $225m for Type II diabetes trial April 28, 2015 by Brad Perriello
Intarcia Therapeuti... | massdevice... |
| 28.04.2015 | Intarcia adds $225m for Type II diabetes trial | Intarcia Therapeutics yesterday took its total raise to more than $1 billion with a $225 million fun... | massdevice... |
| 20.03.2015 | Intarcia and Numab to develop once-yearly therapies in diabe... |
Intarcia Therapeutics, Inc. and Numab AG today announced a strategic collaboration focused on the ... | startuptic... |
| 27.12.2014 | These 20 companies achieved $1B+ valuations in 2014 (updated... | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn m... | venturebea... |
| 27.12.2014 | These 20 companies achieved $1B+ valuations in 2014 (updated... | Update 12/29: We’ve added AdYen.
Update 12/30: We’ve added IronSource.
Update 1/6/2015: We’ve adde... | venturebea... |
| 12.11.2014 | Diabetes: Intarcia inks $1B development deal with Servier | Intarcia Therapeutics said today that French pharmaceutical independent Servier agreed to a deal to ... | massdevice... |
| 10.07.2014 | Venture-backed healthcare deals rise to $2.7B in Q2 | States accounting for the most deal activity Although Pennsylvania has a thriving biotechnology and ... | medcitynew... |
| 02.04.2014 | Intarcia Therapeutics Raises $200m Financing | Intarcia Therapeutics, a Boston, MA-based biotech company, raised $200m in financing.
The round was... | finsmes.co... |
| 01.04.2014 | Intarcia Secures $200M Financing |
BOSTON, MA, Intarcia Therapeutics, Inc. today announced the completion of another landmark private... | vcnewsdail... |
| 16.11.2012 | Diabetes: Intarcia pulls down $210M for drug-device combo| W... | Intarcia Therapeutics said it’s reeled in financing worth a total of $210 million to further its dru... | massdevice... |
| 15.11.2012 | Intarcia Therapeutics Bags Mega $210M |
HAYWARD, CA, Financing consisted of $160 million in proceeds from a preferred stock private placem... | vcnewsdail... |
| 15.11.2012 | Intarcia raises $210M for PhIII, once-yearly diabetes drug | Offering another example of just how expensive it is for a biotech company to develop a new diabetes... | fiercebiot... |
| 04.10.2010 | Industry Ventures raising $300 million fund | Promoted
Telemedicine’s potential to provide healthcare to the world’s most vulnerable
Teladoc Hea... | medcitynew... |
| 08.09.2010 | What you need to know - Thursday 9/8/2010 | Kno raises $46 million, Amazon buys Amie Street, Aircell raises $176M, Google announcement coming?
... | vator.tv/n... |
| 20.03.2007 | Intarcia restarts with $50M for hepatitis, diabetes treatmen... | Intarcia, an Emeryville biopharma company developing treatments for hepatitis C and type 2 diabetes,... | venturebea... |
| - | Industry Ventures raising $300 million fund | Industry Ventures, which invests in other venture and angel funds but has also made direct investmen... | medcitynew... |
| - | Venture-backed healthcare deals rise to $2.7B in Q2 | About $13.88 billion in venture capital backed 974 deals in the second quarter, the highest level si... | medcitynew... |
| - | NEA’s Ed Mathers talks biopharma investment trends and why i... | It’s safe to say Ed Mathers has accrued some industry know-how after 35 years in the biopharmaceutic... | medcitynew... |
| - | Intarcia’s type 2 diabetes implant more effective than top-s... | In terms of controlling Type 2 diabetes and potentially obesity, Boston’s Intarcia Therapeutics just... | medcitynew... |
